Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal of Medicinal Chemistry
|
May 19, 2018
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme
Francesco Merlino, Simona Daniele, Valeria La Pietra, et al.
Archiv Der Pharmazie
|
December 19, 2023
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors
Greta Donati, Monica Viviano, Vincenzo Maria D'Amore, et al.
European Journal of Medicinal Chemistry
|
May 7, 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models
Martina Menna, Francesco Fiorentino, Biagina Marrocco, et al.
European Journal of Medicinal Chemistry
|
September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification
Anna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.
European Journal of Medicinal Chemistry
|
July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
Journal of Medicinal Chemistry
|
August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach
Julian Engel, André Richters, Matthäus Getlik, et al.
Journal of Medicinal Chemistry
|
May 5, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors
Holger Greschik, Florian Friedrich, Ludwig Seifert, et al.
Oncotarget
|
June 8, 2018
Combined HAT/EZH2 modulation leads to cancer-selective cell death
Francesca Petraglia, Abhishek A Singh, Vincenzo Carafa, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal of Medicinal Chemistry
|
May 19, 2018
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme
Francesco Merlino, Simona Daniele, Valeria La Pietra, et al.
Archiv Der Pharmazie
|
December 19, 2023
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors
Greta Donati, Monica Viviano, Vincenzo Maria D'Amore, et al.
European Journal of Medicinal Chemistry
|
May 7, 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models
Martina Menna, Francesco Fiorentino, Biagina Marrocco, et al.
European Journal of Medicinal Chemistry
|
September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification
Anna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.
European Journal of Medicinal Chemistry
|
July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
Journal of Medicinal Chemistry
|
August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach
Julian Engel, André Richters, Matthäus Getlik, et al.
Journal of Medicinal Chemistry
|
May 5, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors
Holger Greschik, Florian Friedrich, Ludwig Seifert, et al.
Oncotarget
|
June 8, 2018
Combined HAT/EZH2 modulation leads to cancer-selective cell death
Francesca Petraglia, Abhishek A Singh, Vincenzo Carafa, et al.
Page
of 5